Cogentix Medical Reports 83% Second Quarter Revenue Growth
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Roth Capital Upgrades Cogentix Medical (CGNT) to Buy
November 5, 2015 7:24 AM ESTRoth Capital upgraded Cogentix Medical (NASDAQ: CGNT) from Neutral to Buy with a price target of $3.00 (from $1.85).
Analyst Chris Lewis commented, "Given our confidence for CGNT to sustain double-digit revenue growth with opportunities for acceleration as EndoSheath sales productivity materializes, paired with notable... More
Cogentix Medical (CGNT) Misses Q2 EPS by 2c
November 3, 2015 4:51 PM ESTCogentix Medical (NASDAQ: CGNT) reported Q2 EPS of ($0.09), $0.02 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $11.8 million versus the consensus estimate of $11.45 million.
Cogentix Medical sees FY2015 revenue of $49-51 million, versus the consensus of $50.0 million.
For earnings... More
